Ausgabe 12/2021
Inhalt (10 Artikel)
Current Opinion
Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
Theocharis Koufakis, Omar G. Mustafa, Vasilios Tsimihodimos, Ramzi A. Ajjan, Kalliopi Kotsa
Therapy in Practice
Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care
Stephan Jacob, Andrew J. Krentz, John Deanfield, Lars Rydén
Review Article
Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Konstantinos E. Iliodromitis, Sotiria G. Giotaki, Charalampos Kossyvakis, Konstantinos Raisakis, Andreas Kaoukis, Vaia Lambadiari, Dimitrios Avramides, Bernhard Reimers, Giulio G. Stefanini, Michael Cleman, Georgios Giannopoulos, Alexandra Lansky, Spyridon G. Deftereos
Open Access
Review Article
Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
Pim Aarts, Koen Dudink, Allard R. J. V. Vossen, Kelsey R. van Straalen, Christine B. Ardon, Errol P. Prens, Hessel H. van der Zee
Open Access
Correction
Correction to: Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Pérez-Jeldres, Manuel Alvarez-Lobos, Jesús Rivera-Nieves